100PercentFedUp.com By Danielle
Moderna has launched a trial for an experimental mRNA ‘vaccine’ for cancer in the United Kingdom.
The therapy, which utilizes technology from the COVID-19 shots, was given to patients at Imperial College Healthcare NHS Trust.
“Cancer patients in the UK are receiving a new therapeutic to help their bodies recognize and fight cancer cells as part of a global trial,” Imperial College London stated.
New mRNA cancer vaccine from Moderna trialed in British patients https://t.co/d1jbNkKTad
— Living Forever (@LivingForever8) February 4, 2024
Imperial College London announced:
The first UK patients received the experimental mRNA therapy – a type of immunotherapy treatment called mRNA-4359 – at Imperial College Healthcare NHS Trust as part of a phase 1/2 clinical trial. The trial aims to evaluate its safety and potential for treating melanoma, lung cancer and other ‘solid tumour’ cancers.
The treatment is designed using messenger RNA (mRNA) and works by presenting common markers of tumours to the patient’s immune system. This should help to train patients’ immune systems to recognise and fight cancer cells expressing these markers, but also potentially eliminate cells that may suppress the immune response…
READ FULL ARTICLE HERE…’ * 100PercentFedUp.com * by Danielle
Home | Caravan to Midnight (zutalk.com)
Be First to Comment